Aetna Increases Sales but Misses Estimates on Earnings
Aetna (NYS: AET) reported earnings on April 26. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Aetna beat slightly on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue grew and GAAP earnings per share dropped.
Margins dropped across the board.
Aetna reported revenue of $8.86 billion. The 10 analysts polled by S&P Capital IQ anticipated revenue of $8.71 billion on the same basis. GAAP reported sales were 6.3% higher than the prior-year quarter's $8.39 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Non-GAAP EPS came in at $1.34. The 18 earnings estimates compiled by S&P Capital IQ averaged $1.40 per share on the same basis. GAAP EPS of $1.43 for Q1 were 4.7% lower than the prior-year quarter's $1.50 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 28.6%, 190 basis points worse than the prior-year quarter. Operating margin was 9.5%, 200 basis points worse than the prior-year quarter. Net margin was 5.7%, 130 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $8.77 billion. On the bottom line, the average EPS estimate is $1.36.
Next year's average estimate for revenue is $35.09 billion. The average EPS estimate is $5.15.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 578 members out of 625 rating the stock outperform, and 47 members rating it underperform. Among 194 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 187 give Aetna a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Aetna is outperform, with an average price target of $53.86.
The healthcare investing landscape is littered with also-rans and a few major winners. Is Aetna prepared for the future? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will deliver amazing returns during the next few years. Click here for instant access to this free report.
- Add Aetna to My Watchlist.
At the time this article was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.